Status
Conditions
Treatments
About
Compare the clinical and radiographic outcomes of demineralized dentin matrix scaffold to blood clot scaffold in immature permanent incisors with non-vital pulps for one year (in vivo).
Investigate the effect of demineralized dentin matrix (DDM) on dental pulp stem cells (DPSCs) (in vitro).
Full description
Necrosis of the immature pulp not only is one of the multiple factors affecting long-term tooth endurance and preservation but also can act as a source of bacterial infection in the periapical area and even the maxillofacial spaces
A fundamental component of the regenerative endodontic process is the presence of a scaffold for stem cells from the apical papilla to adhere, multiply and differentiate. Based on the results of many studies, the use of blood clot Regenerative procedure is not considered a true scaffold system. But it is an essential part of any appropriately designed tissue engineering regenerative endodontic strategy
.
Different treatment options and scaffolds have been tested in regenerative endodontics. Only
some of them exhibited clinical relevance such as blood clot, platelet-rich plasma, and platelet- rich fibrin as RET scaffolds. Therefore, the use of a suitable scaffold is an essential part of tissue
engineering regenerative endodontic strategy .
Hence, developing a new dental material that retains the proteins or factors that can stimulate regenerative processes close to the natural process seems promising . Tissue-derived extracellular matrices have recently been known as naturally-derived scaffolds for tissue regeneration in various applications and have been revealed to serve as a cultural substrate on which cells tend to adhere to and proliferate well and can induce regeneration specific to tissues and sites
A new extracellular matrix material, demineralized dentin matrix (DDM) derived from extracted teeth has been found to act as a biocompatible scaffold for the attachment, differentiation, and proliferation of human DPSCs (dental pulp stem cell) into odontoblast-like cells . The dentin matrix has proposed roles for directing mineralized tissue repair in dentine and bone; however, the range of bioactive components in dentine and specific biological effects on bone-derived mesenchymal stem cells (MSCs) in humans are less well understood
.
DDM is an autogenous tooth dentin that has osteoconductive and osteoinductive potential since it contains extracellular collagen-1 and various growth factors. DDM as a solid blocky material has less physical stability and sealing ability as a material for regenerative endodontics.
Therefore it has been further fabricated into the forms of DDM powder, gel, and sheets to maintain bioactivity .
DDM can be prepared with low risks of infection and rejection with noninvasive attainability; thus, it should be considered a natural resource to be used to full advantage for other applications
indicated that DDM as a regenerative biomaterial has potential roles in tissue regeneration. However, to confirm these trials, further well-designed analyses are needed, and an evaluation of adverse events in observational studies is also needed. To our knowledge, DDM has not been investigated as a scaffold in regenerative endodontics for permanent teeth. Several studies evaluated the regenerative effect of DDM on the dentin-pulp complex through the direct pulp capping technique, and it was found to possess the ability to activate the odontogenic differentiation of stem cells resident in the pulp tissues and induce reparative dentin formation. DDM is also considered for the alveolar ridge, maxillary sinus floor augmentations, socket preservation, furcation perforation repair, guided bone, and bio root regenerations as well as bone and cartilage healing
.
Hence, this study will be designed to evaluate the regenerative effect of Demineralized Dentin Matrix as a scaffold in comparison to a conventional blood clot in immature permanent teeth.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria : patients clinical examination Must be include the following
Primary purpose
Allocation
Interventional model
Masking
30 participants in 3 patient groups
Loading...
Central trial contact
Marwa Abozed; mariem wassel
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal